News | January 10, 2024
Hikal invests Rs. 500 crore into fine chemicals plant at Panoli
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
Launch innovative vitamin sublingual sprays
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in Aptivate Champion Run
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Medway setup a state-of-the-art Heart Institute in Chennai
The company has received five final approvals
Subscribe To Our Newsletter & Stay Updated
